Author

Xiaowei Gu

Observed name: X. Gu

Institution: Jiangyin People's Hospital

Observed institutions: Nantong University, Peking University Cancer Hospital, Jiangyin People's Hospital, Peking University First Hospital

ORCID: 0000-0001-8501-5305

Observed ORCID: 0000-0001-8501-5305

OpenAlex ID: A5029801156

The role of radiomics for predicting of lymph-vascular space invasion in cervical cancer patients based on artificial intelligence: a systematic review and meta-analysis

2024 · Mengli Zhao, Zhen Li, et al. · Journal of Gynecologic Oncology · 8

ESO-Shanghai 20: phase III clinical trial of anti-PD-1 therapy with local intervention for oligometastatic ESCC

2025 · Guangmin Mao, Zhuocheng Xin, et al. · Future Oncology · 3

Prognostic Significance of PD-L1 Expression in Patients with Head and Neck Squamous Cell Carcinoma

2017 · C. Peng, X.S. Gao, et al. · International Journal of Radiation Oncology*Biology*Physics · 1

PV-0508: Prognostic significance of PD-L1 expression in patients with head and neck squamous cell carcinoma

2017 · C. Peng, X. Gu, et al. · Radiotherapy and Oncology · 1

Phase I Clinical Trial of Lobaplatin Combined with Image-Guided Volume-Modulated Arc Radiation Therapy in Locally Advanced Cervical Cancer

2024 · J. You, X. Gu, et al. · International Journal of Radiation Oncology*Biology*Physics

Works count: 5

Citation count: 13

H-index: 2

I10-index: